Health Tech Capitol | Zurex Pharma moves toward filing for FDA approval of its surgical antiseptic
16283
post-template-default,single,single-post,postid-16283,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Zurex Pharma moves toward filing for FDA approval of its surgical antiseptic

01 Jul Zurex Pharma moves toward filing for FDA approval of its surgical antiseptic

Posted at 14:18h in Uncategorized by
0 Likes

Zurex Pharma, a Middleton company with a new type of antiseptic for surgical wounds, is getting a boost from investors as it prepares to file for approval of its first product from federal regulators.

Zurex has added $9 million to its coffers, raising the total received so far to $28 million.

Zurex president and CEO Carmine Durham said ZurexPrep is a new type of antimicrobial solution designed to prevent infections from forming after surgery. Durham said isopropyl alcohol does “a pretty good job by itself” in killing bacteria, but it dries quickly.

“Our proprietary formula actually supports the effect of the alcohol better,” he said. “We have a unique formula using small amounts of paraben and citrate.”

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.